MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gurr, J.-R.
Right arrow Articles by Jan, K.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gurr, J.-R.
Right arrow Articles by Jan, K.-Y.

Vol. 56, Issue 1, 102-109, July 1999

Dithiothreitol Enhances Arsenic Trioxide-Induced Apoptosis in NB4 Cells

Jia-Ran Gurr, Da-Tian Bau, Fount Liu, Shugene Lynn, and Kun-Yan Jan

Institute of Zoology, Academia Sinica, Taipei, Republic of China

Recently, arsenic trioxide (As2O3) was reported to induce clinical remission in patients with acute promyelocytic leukemia. Modulation of protein phosphorylation by binding to the vicinal thiols has been suggested as a possible mechanism. We found that phenylarsine oxide, a strong vicinal thiol-binding agent, neither induced nuclear fragmentation or DNA laddering nor increased caspase activity in NB4 cells; however, As2O3 and a weak thiol-binding agent, dimethylarsinic acid, did increase activity. Dithiothreitol (DTT) effectively suppressed the phenylarsine oxide-inhibited cellular reductive capacity, but unexpectedly, enhanced As2O3-induced apoptosis in NB4 cells. As2O3-induced and As2O3-plus-DTT-induced apoptosis in NB4 cells was modulated by oxidant modifiers, but not by nitric oxide synthase inhibitors. These results demonstrate that DTT, a dithiol agent and known antidote for trivalent inorganic arsenic, enhances the toxicity of As2O3, thereby opening a new research direction for the mechanisms of arsenic toxicity and perhaps also helping in the development of new therapeutic strategies for treating leukemias.

Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Evid Based Complement Alternat MedHome page
S. C. Kim, S. J. Park, J. R. Lee, J. C. Seo, C. H. Yang, and S. H. Byun
Cytoprotective Activity of Glycyrrhizae radix Extract Against Arsenite-induced Cytotoxicity
Evid. Based Complement. Altern. Med., June 1, 2008; 5(2): 165 - 171.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
K.-Y. Jan, T.-C. Wang, B. Ramanathan, and J.-R. Gurr
Dithiol Compounds at Low Concentrations Increase Arsenite Toxicity
Toxicol. Sci., April 1, 2006; 90(2): 432 - 439.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. Ramanathan, K.-Y. Jan, C.-H. Chen, T.-C. Hour, H.-J. Yu, and Y.-S. Pu
Resistance to Paclitaxel Is Proportional to Cellular Total Antioxidant Capacity
Cancer Res., September 15, 2005; 65(18): 8455 - 8460.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Y.-H. Ling, J.-D. Jiang, J. F. Holland, and R. Perez-Soler
Arsenic Trioxide Produces Polymerization of Microtubules and Mitotic Arrest before Apoptosis in Human Tumor Cell Lines
Mol. Pharmacol., September 1, 2002; 62(3): 529 - 538.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W. H. Miller Jr., H. M. Schipper, J. S. Lee, J. Singer, and S. Waxman
Mechanisms of Action of Arsenic Trioxide
Cancer Res., July 15, 2002; 62(14): 3893 - 3903.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
L.-H. Yih, K. Peck, and T.-C. Lee
Changes in gene expression profiles of human fibroblasts in response to sodium arsenite treatment
Carcinogenesis, May 1, 2002; 23(5): 867 - 876.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
D.T. Bau, J.R. Gurr, and K.Y. Jan
Nitric oxide is involved in arsenite inhibition of pyrimidine dimer excision
Carcinogenesis, May 1, 2001; 22(5): 709 - 716.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics